NEWGENIVF GROUP LTD-A(NASDAQ:NIVF) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to NIVF. NIVF was compared to 109 industry peers in the Health Care Providers & Services industry. NIVF has a bad profitability rating. Also its financial health evaluation is rather negative. NIVF is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NIVF has reported negative net income.

In the past year NIVF has reported a negative cash flow from operations.

1.2 Ratios

NIVF's Return On Assets of -3.22% is in line compared to the rest of the industry. NIVF outperforms 45.37% of its industry peers.

Looking at the Return On Equity, with a value of -4.40%, NIVF is in line with its industry, outperforming 52.78% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-3.22%
ROE	-4.4%
ROIC	N/A

ROA(3y)-0.84%

ROA(5y)N/A

ROE(3y)-1.23%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NIVF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for NIVF has been reduced compared to 1 year ago.

Compared to 1 year ago, NIVF has a worse debt to assets ratio.

2.2 Solvency

NIVF has an Altman-Z score of -0.61. This is a bad value and indicates that NIVF is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of NIVF (-0.61) is worse than 80.56% of its industry peers.

NIVF has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.

With a decent Debt to Equity ratio value of 0.10, NIVF is doing good in the industry, outperforming 74.07% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Altman-Z	-0.61

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

NIVF has a Current Ratio of 0.02. This is a bad value and indicates that NIVF is not financially healthy enough and could expect problems in meeting its short term obligations.

NIVF has a Current ratio of 0.02. This is amonst the worse of the industry: NIVF underperforms 96.30% of its industry peers.

NIVF has a Quick Ratio of 0.02. This is a bad value and indicates that NIVF is not financially healthy enough and could expect problems in meeting its short term obligations.

NIVF has a Quick ratio of 0.02. This is amonst the worse of the industry: NIVF underperforms 96.30% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.02
Quick Ratio	0.02

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NIVF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -196.55%.

EPS 1Y (TTM)-196.55%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-346.55%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NIVF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NIVF!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEWGENIVF GROUP LTD-A

NASDAQ:NIVF (1/31/2025, 6:27:40 PM)

After market: 0.1488 0 (-0.13%)

0.149

-0.11 (-42.47%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners28.69%

Inst Owner Change0%

Ins Owners45.84%

Ins Owner Change0%

Market Cap1.51M

AnalystsN/A

Price TargetN/A

Short Float %4.08%

Short Ratio0.04

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.1
P/tB	0.1
EV/EBITDA	N/A

EPS(TTM)-0.1

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.08

FCFYN/A

OCF(TTM)-0.08

OCFYN/A

SpS0

BVpS1.54

TBVpS1.54

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.22%
ROE	-4.4%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-0.84%

ROA(5y)N/A

ROE(3y)-1.23%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.02
Quick Ratio	0.02
Altman-Z	-0.61

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-196.55%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-346.55%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-395.36%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-61.77%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-61.77%

OCF growth 3YN/A

OCF growth 5YN/A

NEWGENIVF GROUP LTD-A (NIVF) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens